- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x BEF: BERYLLIUM TRIFLUORIDE ION(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.4: 25 residues within 4Å:- Chain A: Y.241, Y.259, I.266, S.270, L.273, S.274, K.277, T.278, A.472, A.475, A.476, T.478, V.479, L.482, I.496, H.497, P.498, L.499, M.937, T.971, T.972, A.975, V.976
- Ligands: Y01.3, CLR.7
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.266, A:A.472, A:A.475, A:A.475
- Hydrogen bonds: A:K.277, A:H.497
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.6: 12 residues within 4Å:- Chain A: A.1063, L.1075, Y.1076, L.1082, L.1085, A.1086, S.1089, S.1090, F.1128, F.1132
- Ligands: D10.19, D10.20
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.1075, A:L.1075, A:Y.1076, A:L.1082, A:L.1082, A:L.1085, A:A.1086, A:F.1132
CLR.7: 12 residues within 4Å:- Chain A: L.261, C.262, L.265, I.266, I.269, L.273, L.482
- Ligands: Y01.3, LMT.4, D10.12, D10.13, D12.16
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.261, A:L.265, A:I.266, A:I.269
CLR.21: 13 residues within 4Å:- Chain A: N.238, P.239, Y.240, F.243, K.427, V.429, S.433, A.436, L.437, V.465, V.469
- Ligands: D10.17, CLR.22
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:P.239, A:Y.240, A:F.243, A:V.429
CLR.22: 7 residues within 4Å:- Chain A: P.239, G.242, F.243, F.246, L.462
- Ligands: D10.17, CLR.21
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:P.239
- 10 x D10: DECANE(Non-covalent)(Non-functional Binders)
D10.9: 8 residues within 4Å:- Chain A: L.977, V.1079, P.1080, V.1083, A.1084, L.1087
- Ligands: Y01.5, D10.10
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.1083, A:L.1087
D10.10: 5 residues within 4Å:- Chain A: R.980, P.1080
- Ligands: Y01.5, D10.9, D10.11
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:P.1080
D10.11: 4 residues within 4Å:- Ligands: Y01.3, Y01.5, D10.10, D10.13
No protein-ligand interaction detected (PLIP)D10.12: 5 residues within 4Å:- Chain A: I.269, L.273
- Ligands: CLR.7, D10.13, D10.14
No protein-ligand interaction detected (PLIP)D10.13: 4 residues within 4Å:- Ligands: Y01.3, CLR.7, D10.11, D10.12
No protein-ligand interaction detected (PLIP)D10.14: 4 residues within 4Å:- Chain A: C.272, L.273, Y.276
- Ligands: D10.12
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.276
D10.17: 4 residues within 4Å:- Chain A: P.239, V.429
- Ligands: CLR.21, CLR.22
No protein-ligand interaction detected (PLIP)D10.18: 7 residues within 4Å:- Chain A: G.1115, L.1118, L.1119, L.1121, G.1122, T.1125
- Ligands: D10.20
No protein-ligand interaction detected (PLIP)D10.19: 6 residues within 4Å:- Chain A: F.1128, V.1129, F.1132, M.1133, S.1136
- Ligands: CLR.6
No protein-ligand interaction detected (PLIP)D10.20: 10 residues within 4Å:- Chain A: F.1056, I.1060, S.1089, V.1093, L.1121, V.1124, T.1125, F.1128
- Ligands: CLR.6, D10.18
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.1121, A:F.1128, A:F.1128
- 1 x C14: TETRADECANE(Non-covalent)
- 1 x D12: DODECANE(Non-covalent)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x SPK: SPERMINE (FULLY PROTONATED FORM)(Non-covalent)
SPK.24: 16 residues within 4Å:- Chain A: W.251, D.254, H.255, Y.256, Y.259, R.460, D.463, T.466, V.467, Y.940, Q.944, N.957, D.960, F.963, D.967, P.1039
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:V.467, A:F.963, A:F.963
- Hydrogen bonds: A:D.463, A:Q.944, A:D.960, A:D.967
- Water bridges: A:Y.940
- 1 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
EUJ.25: 16 residues within 4Å:- Chain A: P.993, G.994, A.995, L.997, S.998, V.999, P.1000, L.1002, L.1146, L.1149, R.1150, R.1153, S.1155, K.1156, K.1157, K.1160
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:V.999, A:L.1002
- Hydrogen bonds: A:G.994, A:A.995, A:V.999, A:R.1153, A:S.1155, A:S.1155
- Salt bridges: A:R.1153, A:K.1160
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tillinghast, J. et al., Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2. Mol.Cell (2021)
- Release Date
- 2022-03-30
- Peptides
- Polyamine-transporting ATPase 13A2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x BEF: BERYLLIUM TRIFLUORIDE ION(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 10 x D10: DECANE(Non-covalent)(Non-functional Binders)
- 1 x C14: TETRADECANE(Non-covalent)
- 1 x D12: DODECANE(Non-covalent)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x SPK: SPERMINE (FULLY PROTONATED FORM)(Non-covalent)
- 1 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tillinghast, J. et al., Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2. Mol.Cell (2021)
- Release Date
- 2022-03-30
- Peptides
- Polyamine-transporting ATPase 13A2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.